SCHEMBL30456839

SCHEMBL30456839

O=C(O)NCCCCCN1CCC[C@H](NC(=O)OCc2ccccc2)C1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.52
▸ CTSB P07858 1/20 0.52
▸ CTSK P43235 1/20 0.52
▸ EPHX1 P07099 1/20 0.48
▸ DPP7 Q9UHL4 3/20 0.48
▸ DPP4 P27487 2/20 0.48
▸ DPP8 Q6V1X1 2/20 0.48
▸ DPP9 Q86TI2 1/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ KEAP1 Q14145 1/20 0.46
▸ NFE2L2 Q16236 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ HSD11B1 P28845 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ TGM2 P21980 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31220668 0.89 ITGB3 (0.50) CTSLCTSBCTSKDPP7DPP4
SCHEMBL25363506 0.89 ITGB3 (0.50) CTSLCTSBCTSKDPP7DPP4
SCHEMBL18342444 0.85 CTSL (0.60) CTSLCTSBCTSKEPHX1DPP7
SCHEMBL18342447 0.85 CTSL (0.60) CTSLCTSBCTSKEPHX1DPP7
SCHEMBL31220688 0.83 CTSL (0.51) CTSLCTSBCTSKKEAP1NFE2L2
SCHEMBL29255622 0.81 CTSL (0.60) CTSLCTSBCTSKEPHX1DPP7
SCHEMBL28249925 0.79 CTSK (0.60) CTSLCTSBCTSKEPHX1DPP7
SCHEMBL28805923 0.78 OPRM1 (0.58) CTSLCTSBCTSKEPHX1MEN1
SCHEMBL28805924 0.78 OPRM1 (0.58) CTSLCTSBCTSKEPHX1MEN1
SCHEMBL13737251 0.78 HTT (0.60) DPP7DPP4DPP8DPP9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116761-A1 PYRIMIDINE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE 英矽智能科技知识产权有限公司 2023-06-29 — — WO disclosed
Send feedback